skynesher/E+ via Getty Images
- Psyence Biomedical (NASDAQ:PBM) said Wednesday it received a letter from Nasdaq for not meeting the minimum bid price of $1.00 per share required for continued listing.
- Psyence Biomedical (PBM) has 180 calendar days, or until December 24, 2024 to regain compliance with the Minimum Bid Price Rule.
- Source: Press Release